Optimal surgical margin for hepatocellular carcinoma following HAIC-based conversion therapy: a target trial emulation study

The oncological necessity of wide surgical margins for hepatocellular carcinoma (HCC) following successful conversion therapy remains an unsettled debate. Extrapolating the conventional 1 cm rule from chemotherapy-naïve populations ignores the unique locoregional sterilization induced by hepatic arterial infusion chemotherapy (HAIC). This study leverages a causal inference framework to delineate the optimal resection extent for this distinct patient cohort. Utilizing a target trial emulation approach, we analyzed observational data from patients undergoing curative R0 resection after HAIC-mediated conversion. The study population was stratified based on margin width greater or less than 1 cm, with baseline confounders balanced via stabilized inverse probability of treatment weighting. We further validated the findings through multiple sensitivity analyses at explicitly labelled alternative thresholds ( ≥ 0.5 cm vs. < 0.5 cm; > 0 cm vs. 0 cm; and 0.1 cm vs. 0 cm) to ensure the stability of our causal conclusions. Analysis of the weighted cohort demonstrated that a narrow resection margin delivered overall survival (OS: HR, 0.96; 95% CI: 0.70–1.31; P = 0.784) and recurrence-free survival (RFS: HR, 0.83; 95% CI: 0.65–1.06; P = 0.136) rates statistically indistinguishable from those achieved with a wide margin. This prognostic equivalence persisted across comprehensive sensitivity testing at varying cut-off values. Exploratory subgroup interactions suggested that extended clearances might offer a survival advantage specifically for high-risk phenotypes. A 1 cm resection margin was not associated with improved OS or RFS after HAIC-based conversion surgery. These findings suggest that a microscopically negative R0 margin may be an adequate surgical endpoint in this setting. These data do not support routine resection beyond a negative R0 margin, and extended resections may instead be reserved for biologically aggressive subtypes.

Authors

Institutions

Publication Details

Journal
BMC Medicine
Published
2026-11-19
DOI
https://doi.org/10.1186/s12916-026-05421-7
Primary Topic
Hepatocellular Carcinoma Treatment and Prognosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Optimal surgical margin for hepatocellular carcinoma following HAIC-based conversion therapy: a target trial emulation study

Hao Cai, 陈焕伟, Rong Guo, Chong Zhong et al.
BMC Medicine
Hepatocellular Carcinoma Treatment and Prognosis
article

Optimal surgical margin for hepatocellular carcinoma following HAIC-based conversion therapy: a target trial emulation study

Hao Cai, 陈焕伟, Rong Guo, Chong Zhong, 陈祖兵, Yuxiong Qiu, Wei Qin, Yajun Tang, Benyi He, Min Deng, Fengting Lai, Dong Li, Di Tang, Wei Wei
article en

Abstract

The oncological necessity of wide surgical margins for hepatocellular carcinoma (HCC) following successful conversion therapy remains an unsettled debate. Extrapolating the conventional 1 cm rule from chemotherapy-naïve populations ignores the unique locoregional sterilization induced by hepatic arterial infusion chemotherapy (HAIC). This study leverages a causal inference framework to delineate the optimal resection extent for this distinct patient cohort. Utilizing a target trial emulation approach, we analyzed observational data from patients undergoing curative R0 resection after HAIC-mediated conversion. The study population was stratified based on margin width greater or less than 1 cm, with baseline confounders balanced via stabilized inverse probability of treatment weighting. We further validated the findings through multiple sensitivity analyses at explicitly labelled alternative thresholds ( ≥ 0.5 cm vs. < 0.5 cm; > 0 cm vs. 0 cm; and 0.1 cm vs. 0 cm) to ensure the stability of our causal conclusions. Analysis of the weighted cohort demonstrated that a narrow resection margin delivered overall survival (OS: HR, 0.96; 95% CI: 0.70–1.31; P = 0.784) and recurrence-free survival (RFS: HR, 0.83; 95% CI: 0.65–1.06; P = 0.136) rates statistically indistinguishable from those achieved with a wide margin. This prognostic equivalence persisted across comprehensive sensitivity testing at varying cut-off values. Exploratory subgroup interactions suggested that extended clearances might offer a survival advantage specifically for high-risk phenotypes. A 1 cm resection margin was not associated with improved OS or RFS after HAIC-based conversion surgery. These findings suggest that a microscopically negative R0 margin may be an adequate surgical endpoint in this setting. These data do not support routine resection beyond a negative R0 margin, and extended resections may instead be reserved for biologically aggressive subtypes.

BMC Medicine
Sun Yat-sen University (CN), Shanghai Jiao Tong University (CN), The Seventh Affiliated Hospital of Sun Yat-sen University (CN), First Affiliated Hospital of Guangzhou University of Chinese Medicine (CN), Shanghai First People's Hospital (CN), Sun Yat-sen University Cancer Center (CN), State Key Laboratory of Oncology in South China (CN)
Hepatocellular Carcinoma Treatment and Prognosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon